LISA, Francesco
 Distribuzione geografica
Continente #
NA - Nord America 1.161
EU - Europa 848
AS - Asia 469
SA - Sud America 17
AF - Africa 6
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 3
Totale 2.509
Nazione #
US - Stati Uniti d'America 1.134
CN - Cina 360
IT - Italia 126
IE - Irlanda 119
SE - Svezia 108
UA - Ucraina 88
FR - Francia 79
AT - Austria 69
DE - Germania 66
FI - Finlandia 61
KR - Corea 59
GB - Regno Unito 49
BE - Belgio 29
CA - Canada 25
IN - India 22
PL - Polonia 17
VN - Vietnam 13
ES - Italia 12
AR - Argentina 6
BR - Brasile 6
AU - Australia 4
GR - Grecia 4
SN - Senegal 4
CL - Cile 3
EU - Europa 3
JP - Giappone 3
MK - Macedonia 3
QA - Qatar 3
TR - Turchia 3
AL - Albania 2
CZ - Repubblica Ceca 2
HU - Ungheria 2
IL - Israele 2
NL - Olanda 2
PT - Portogallo 2
SI - Slovenia 2
UZ - Uzbekistan 2
BG - Bulgaria 1
CO - Colombia 1
CR - Costa Rica 1
DK - Danimarca 1
DZ - Algeria 1
EE - Estonia 1
ID - Indonesia 1
MU - Mauritius 1
MX - Messico 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PE - Perù 1
RS - Serbia 1
RU - Federazione Russa 1
SG - Singapore 1
Totale 2.509
Città #
Beijing 313
Chandler 211
Dublin 118
Jacksonville 85
Ann Arbor 68
Vienna 68
Houston 59
Villeurbanne 50
Medford 44
Princeton 40
Torino 38
Dearborn 37
Nyköping 35
Wilmington 31
Brussels 29
Fairfield 23
Boardman 22
Ashburn 19
Milan 19
Redwood City 17
New York 15
Warsaw 14
Toronto 13
Pune 12
Fremont 11
Boston 9
Nanjing 9
Verona 9
Woodbridge 9
Dong Ket 8
Hefei 8
Lachine 7
Turin 7
Philadelphia 6
Seattle 6
Washington 6
Norwalk 5
Ottawa 5
Rochester 5
Cambridge 4
Chicago 4
Guangzhou 4
Melbourne 4
Pisa 4
Austin 3
Berlin 3
Des Moines 3
Grants Pass 3
Madrid 3
Paris 3
Reggio Nell'emilia 3
Rome 3
Shanghai 3
Skopje 3
Venezia 3
Arcadia 2
Atlanta 2
Baltimore 2
Barcelona 2
Brno 2
Bronx 2
Changchun 2
Chongqing 2
Denver 2
Duncan 2
Falls Church 2
Federal 2
Florence 2
Gurgaon 2
Hadera 2
Hangzhou 2
Harbin 2
Jinan 2
Minneapolis 2
New Orleans 2
Pavia 2
Pittsburgh 2
Poggibonsi 2
Rosario 2
Shaoxing 2
Shenyang 2
Speyer 2
University Park 2
Urbino 2
Viña del Mar 2
Acton 1
Andover 1
Ankara 1
Appleton 1
Bangalore 1
Baotou 1
Belgrade 1
Bergamo 1
Bethesda 1
Bologna 1
Bolzano 1
Bordeaux 1
Borgaro Torinese 1
Brescia 1
Buffalo 1
Totale 1.618
Nome #
Blood Flow Cytometry in Sézary Syndrome: New Insights on Prognostic Relevance and Immunophenotypic Changes During Follow-up. 429
BANS: a discussion of the problem. 115
TERT Promoter Mutations are Associated with Visceral Spreading in Melanoma of the Trunk 107
Functional properties in Sézary cells with an unusual phenotype. 101
Peripheral blood involvement in a mycosis fungoides patient with limited skin lesions: phenotypical features and homing molecule pattern 101
ALK expression favorably impacts the prognosis of NRAS-mutated metastatic melanomas 94
[Cutaneous melanoma at the Turin Melanoma Center. I. Survival and correlation with clinical and histologic prognostic factors in 502 patients in stage I (1975-1985)] 91
Changes in T and B lymphocyte subpopulations before, during and after chemotherapy for malignant melanoma. 89
[Cutaneous melanoma at the Turin Melanoma Center. II. Risk of metastasis and free interval in relation to the clinical and histological prognostic factors in 502 patients in stage I (1975-1985)] 87
Low-dose intermittent alemtuzumab in the treatment of Sézary syndrome: clinical and immunologic findings in 14 patients. 87
Collagenase digestion and mechanical disaggregation as a method to extract and immunophenotype tumour lymphocytes in cutaneous T-cell lymphomas. 80
T-cell subsets in melanoma patients evaluated by anti-T-cell monoclonal antibodies. 78
Low-dose intermittent Alemtuzumab in Sézary Syndrome: clinical activity, toxicity profile and immunological findings in 17 patients. 77
The prognostic value of T-lymphocyte levels in malignant melanoma. A five-year follow-up. 77
Macrophage-mediated immunostimulation modulates therapeutic efficacy of interleukin-2 based chemoimmunotherapy in advanced metastatic melanoma patients. 76
Prognostic factors in Sézary syndrome: a multivariate analysis of clinical, haematological and immunological features. 69
Macrophage-mediated antitumor immunostimulation or immunosuppression modulates IL-2 therapeutic efficacy in advanced metastatic melanoma (MM) patients. 64
Time course and pattern of first relapse in stage I-II primary cutaneous melanoma: a multivariate analysis of disease-free survival in 3,174 patients followed-up at the Turin Melanoma Centre from 1975 to 2004 63
The relevance of the CD4+ CD26- subset in the identification of circulating Sézary cells. 63
Biological prognostic factors in advanced metastatic melanoma patients treated with chemoimmunotheraphy. 62
PAS expression is related to survival in Sézary syndrome patients 60
Clinical presentation and immunological features of an Italian ATL case 60
Prognostic factors in Sezary sindrome 59
The immunological profile of melanoma and the role of adjuvant thymostimulin therapy in stage I patients. 59
Flow cytometry immunophenotyping in mycosis fungoides 57
Significato prognostico dei livelli sierici di interleuchina-12 endogena in pazienti affetti da melanoma metastatico in fase avanzata trattati con chemioterapia o chemioimmunoterapia. 50
Skin infiltrating lymphocyte flow-cytometric immunophenotyping: automated mechanical biopsy disaggregation and CD45 gating. 48
KM-93 expression on peripheral blood lymphocytes (PBL) in inflammatory skin diseases, mycosis fungoides and Sézary syndrome. 44
Thymopentin in Sézary syndrome. 42
In vitro and in vivo effect of thymostimulin in melanoma patients. 38
Soluble interleukin-2 receptor in Sézary syndrome: its origin and clinical application. 37
Soluble interleukin-2 receptor, CD4 and CD8 levels in melanoma: a longitudinal study 33
Totale 2.597
Categoria #
all - tutte 6.633
article - articoli 0
book - libri 0
conference - conferenze 1.303
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.936


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019104 0 0 0 0 0 0 0 35 10 19 27 13
2019/2020358 4 5 15 21 29 68 38 21 54 43 32 28
2020/2021261 34 17 20 20 22 11 22 9 28 20 33 25
2021/2022287 4 10 25 24 7 10 18 9 15 17 70 78
2022/2023594 56 41 18 50 64 149 46 42 66 17 31 14
2023/2024150 37 37 18 16 10 30 2 0 0 0 0 0
Totale 2.597